DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR. Issue 20 (18th October 2022)

• Record Type: Journal Article
• Authors: Guo, Jing; Yu, Junhui; Mu, Mingchao; Chen, Zilu; Xu, Zhengshui; Zhao, Chenye; Yang, Kui; Zheng, Jianbao; Qin, Xiao; Zhao, Wei; Sun, Xuejun
• Is Part Of: Cell cycle. Volume 21:Issue 20(2022)
• Page Start: 2165
• Page End: 2178
• Publication Date: 2022-10-18
• Subjects: DFNA5 -- proliferation -- cell cycle -- mTORC1/2 -- DEPTOR -- colorectal cancer; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2022.2088570
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: The human deafness, autosomal dominant 5 gene (DFNA5), a newly discovered executor of pyroptosis, has been strongly implicated in the tumorigenesis of several human cancers. However, an understanding of the functional role of DFNA5 in the development and progression of colorectal cancer (CRC) is limited. In this study, we demonstrated that DFNA5 was downregulated in CRC tissues. Ectopic expression of DFNA5 inhibited tumor cell growth in vitro, retarded tumor formation in vivo, and blocked a cell-cycle transition from the G0/G1 to the S phase, whereas a DFNA5 knockdown promoted cell proliferation. Western blotting showed that the levels of cell cycle-related proteins, including cyclin D1, cyclin E, CDK2, and p21, were accordingly altered upon DFNA5 overexpression or DFNA5 knockdown. Mechanistic studies indicated that DFNA5 exerted its tumor suppressor functions by antagonizing mTORC1/2 signaling via upregulation of DEPTOR. In addition, blockage of mTORC1/2 signaling by Torin-1 abolished the accelerative proliferation by DFNA5 knockdown. In conclusion, these results indicated that DFNA5 inhibits the proliferation and tumor formation of colon cancer cells by suppressing mTORC1/2 signaling.